Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis

aSydney School of Public Health, The University of Sydney, New South Wales, Australia

bDepartment of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari

cNephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy

dDepartment of Medicine, University of Otago Christchurch, Christchurch, New Zealand

eCentre for Kidney Research, The Children's Hospital at Westmead, Westmead

fCollege of Medicine and Public Health, Flinders University, Adelaide, Australia

Correspondence to Patrizia Natale, Sydney School of Public Health, The University of Sydney, Australia. Tel: +39 3491661950; e-mail: [email protected]

Abbreviations: ACE, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; CI, confidence interval; CINEMA, Confidence In Network Meta-Analysis; GFR, estimated glomerular filtration rate; MAP, mean arterial pressure; MD, mean difference; MRA, mineralocorticoid receptor antagonists; OR, odds ratio; RCT, randomized controlled trials; SONG-TX, Standardized Outcomes in Nephrology – Kidney Transplant

Received 10 September, 2023

Revised 26 November, 2023

Accepted 4 January, 2024

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).

留言 (0)

沒有登入
gif